Core DNA: Coreweave and Nebius Couldn’t Be More Different and Why It Matters

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • CRWV built a $99B backlog as a leveraged GPU platform; NBIS grew AI Cloud 841% as a cash-rich software stack.

  • CoreWeave carries $51B in liabilities on just $2.2B cash, while Nebius holds $9.3B and issued explicit 2026 guidance CoreWeave declined to give.

  • CoreWeave shares fell 29% since its May 7 report, while Nebius's 317% one-year run leaves little room for any quarterly disappointment.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Nebius Group didn't make the cut. Grab the names FREE today.

Core DNA: Coreweave and Nebius Couldn’t Be More Different and Why It Matters

© Andriy Onufriyenko / Moment via Getty Images

CoreWeave (NASDAQ: CRWV) and Nebius Group (NASDAQ: NBIS | NBIS Price Prediction) just delivered Q1 2026 results that look similar on the surface: both are NVIDIA-backed AI cloud providers chasing hyperscaler contracts. Underneath, the businesses are built on completely different foundations. CoreWeave is a leveraged infrastructure developer. Nebius is an AI-native software cloud platform. That distinction shaped everything about their quarters.

Bookings Machine Meets Software Stack

CoreWeave printed $2.08 billion in revenue, up 111.69% year over year, alongside a $99.4 billion revenue backlog anchored by a $21 billion Meta commitment and a fresh Anthropic deal for Claude. CEO Michael Intrator framed the pitch clearly: “We sit between the models and the silicon.” That is the whole thesis. Rent GPUs at scale, wrap them in Weights & Biases tooling, collect long-dated bookings.

Nebius told a different story. Revenue landed at $399 million, missing the $593 million consensus, but Nebius AI Cloud alone grew 841% year over year at a 45% adjusted EBITDA margin. Arkady Volozh is building a full software layer, including Aether 3.5 serverless AI, Token Factory managed inference, and stakes in ClickHouse, Toloka, and Avride autonomous delivery. The company also secured its own $27 billion five-year Meta agreement.

Debt-Fueled Scale vs. Cash-Rich Optionality

The balance sheets reveal the real divergence. CoreWeave carries $50.81 billion in total liabilities against $2.24 billion in cash, with interest expense doubling to $536 million and Q1 capex hitting $7.7 billion. That is the leveraged developer model working in overdrive. Nebius sits on $9.30 billion of cash, having raised $6.3 billion from financing activities, and it actually issued explicit 2026 guidance of $3.0 billion to $3.4 billion in revenue with a ~40% adjusted EBITDA margin. CoreWeave declined to give formal guidance.

Lens CoreWeave Nebius
Core DNA Leveraged infra developer AI-native software platform
Backlog / RPO $99.4B $33.6B
Cash Position $2.24B $9.30B
Key Vulnerability Interest expense, capex Revenue miss, execution

Inference Ramp Will Settle This

Both companies achieved NVIDIA Exemplar Cloud status, but on different systems: GB200 NVL72 for CoreWeave and GB300 NVL72 for Nebius. I will be watching whether CoreWeave’s Dedicated Inference product converts that $99B backlog into cash before debt service compresses margins. For Nebius, the question is whether Token Factory, plus the Tavily, Eigen AI, and Clarifai acquisitions, can push ARR toward the $7 billion to $9 billion year-end target.

What the Setup Signals Right Now

CoreWeave offers the largest hyperscaler bookings pipeline paired with a highly leveraged build-out, though shares are down 28.67% since the May 7 report. On the metrics, Nebius screens as the more defensive profile. The 45% segment EBITDA margin, cleaner balance sheet, and diversified software stack look more defensible if GPU pricing softens. That said, the 316.73% one-year run leaves little room for the next quarter to disappoint.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

EXPE Vol: 1,564,123
DLTR Vol: 2,429,419
CHD Vol: 1,866,626
MO Vol: 10,124,542
GDDY Vol: 1,318,738

Top Losing Stocks

CTRA Vol: 73,319,495
STX Vol: 3,209,876
MU Vol: 30,000,120
JBHT Vol: 1,266,948
SMCI Vol: 39,934,814